Safety and Efficacy of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Individuals: Week 96 Results of the Phase 3 BRIGHTE Study

Max Lataillade; Jacob P Lalezari; Michael Kozal; Judith A Aberg; Gilles Pialoux; Pedro Cahn; Melanie Thompson; Jean-Michel Molina; Santiago Moreno; Beatriz Grinsztejn; Ricardo S Diaz; Antonella Castagna; Princy N Kumar; Gulam H Latiff; Edwin de Jesus; Marcia Wang; Shiven Chabria; Margaret Gartland; Amy Pierce; Peter Ackerman; Cyril Llamoso

doi:10.1016/S2352-3018(20)30240-X

Journal Articles The Lancet HIV Year : 2020

Safety and Efficacy of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Individuals: Week 96 Results of the Phase 3 BRIGHTE Study

(1) , , (2) , , (3, 4) , (5) , , (6) , , (7) , , (8) , , , , (9) , (1) , (9) , (1) , (1) , (1)

1
2
3
4
5
6
7
8
9

Max Lataillade

Function : Author

ViiV Healthcare US

Jacob P Lalezari

Function : Author

Michael Kozal

Function : Author

Yale School of Medicine [New Haven, Connecticut]

Judith A Aberg

Function : Author

Gilles Pialoux

Function : Author

CHU Tenon [AP-HP]

Institut Pierre Louis d'Epidémiologie et de Santé Publique

Pedro Cahn

Function : Author

Fundación Huésped [Buenos Aires]

Melanie Thompson

Function : Author

Jean-Michel Molina

Function : Author

Hopital Saint-Louis [AP-HP]

Santiago Moreno

Function : Author

Beatriz Grinsztejn

Function : Author

Fundação Oswaldo Cruz / Oswaldo Cruz Foundation

Ricardo S Diaz

Function : Author

Antonella Castagna

Function : Author

IRCCS Ospedale San Raffaele [Milan, Italy]

Princy N Kumar

Function : Author

Gulam H Latiff

Function : Author

Edwin de Jesus

Function : Author

Marcia Wang

Function : Author

GlaxoSmithKline [Research Triangle Park]

Shiven Chabria

Function : Author

ViiV Healthcare US

Margaret Gartland

Function : Author

GlaxoSmithKline [Research Triangle Park]

Amy Pierce

Function : Author

ViiV Healthcare US

Peter Ackerman

Function : Author

ViiV Healthcare US

Cyril Llamoso

Function : Author

ViiV Healthcare US

Domains

Human health and pathology

Gestionnaire HAL 3 Sorbonne Université : Connect in order to contact the contributor

https://hal.sorbonne-universite.fr/hal-03793481

Submitted on : Saturday, October 1, 2022-10:27:08 AM

Last modification on : Tuesday, October 1, 2024-3:26:06 PM

Dates and versions

hal-03793481 , version 1 (01-10-2022)

Identifiers

HAL Id : hal-03793481 , version 1
DOI : 10.1016/S2352-3018(20)30240-X

Cite

Max Lataillade, Jacob P Lalezari, Michael Kozal, Judith A Aberg, Gilles Pialoux, et al.. Safety and Efficacy of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Individuals: Week 96 Results of the Phase 3 BRIGHTE Study. The Lancet HIV, 2020, 7 (11), pp.e740-e751. ⟨10.1016/S2352-3018(20)30240-X⟩. ⟨hal-03793481⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

RIIP IPLESP SORBONNE-UNIVERSITE SU-MEDECINE

19 View

0 Download

Safety and Efficacy of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Individuals: Week 96 Results of the Phase 3 BRIGHTE Study

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Altmetric

Share